Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Germany
/
Pharmaceuticals & Biotech
Create a narrative
Merck KGaA
XTRA:MRK Community
1
Narratives
written by author
0
Comments
on narratives written by author
40
Fair Values set
on narratives written by author
Create a narrative
Merck KGaA
Popular
Undervalued
Overvalued
Merck KGaA
WA
Analyst Price Target
Consensus Narrative from 16 Analysts
Continued Demand In Life Sciences And Electronics Will Support Future Prospects
Key Takeaways Strong growth in semiconductor solutions and life sciences boosts Merck's Electronics and Process Solutions sectors, positively impacting future revenue and earnings. Robust healthcare sector sales in oncology and neurology, plus geographical diversification, enhance stability and potential for sustained revenue growth.
View narrative
€183.63
FV
26.2% undervalued
intrinsic discount
4.42%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
24 days ago
author updated this narrative
Your Valuation for
MRK
Merck KGaA
Your Fair Value
€
Current Price
€135.50
3.6% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
26b
2015
2018
2021
2024
2025
2027
2030
Revenue €25.6b
Earnings €3.3b
Advanced
Set as Fair Value